Talk:Neonatal conjunctivitis

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.
	This article is supported by the Ophthalmology task force (assessed as Mid-importance).

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Neonatal conjunctivitis.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Gcleveland15.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 05:06, 17 January 2022 (UTC)[reply]

Possible Additions

I plan to contribute a statement about how most hospitals are required by state law to use eye drops or ointment to prevent the disease soon after birth. I also plan to add that neonatal conjunctivitis may be caused by a blocked tear duct instead of bacterial infection, and the subsequent treatment if it is indeed caused by a blocked tear duct. Additionally, I would like to note that it is possible for newborns to suffer from neonatal conjunctivitis due to reactions with chemicals in common eye drops. Finally, I will add that prophylaxis with a 1% silver nitrate solution has largely been discontinued. The Centers for Disease Control and Prevention, Johns Hopkins Medicine, and the National Center for Biotechnology Information will be my sources.

Sources: http://www.cdc.gov/conjunctivitis/newborns.html

http://www.hopkinsmedicine.org/healthlibrary/conditions/pediatrics/conjunctivitis_90,P01678/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170304/

Gcleveland15 (talk) 18:33, 11 October 2016 (UTC)[reply]

Research/moving this here as it was indented out?

An upcoming meta-analysis will seek to determine if any type of ophthalmia neonatorum prophylaxis reduces the incidence of conjuncitivitis in neonates and to determine which ophthalmia neonatorum prophylaxis is most effective at reducing the incidence of conjunctivitis in neonates.^[1] Eight comparisons to be made in the review include:

Any versus no prophylaxis
Erythromycin versus no prophylaxis
Povidone-iodine versus no prophylaxis
Tetracycline versus no prophylaxis
Erythromycin verus tetracycline
Povidone-iodine versus erythromycin
Povidone-iodine versus tetracycline
Povidone-iodine versus chloramphenicol

References

^ Kapoor VS, Whyte R, Vedula SS (2016). "Interventions for preventing ophthalmia neonatorum". Cochrane Database Syst Rev. 9: CD001862. doi:10.1002/14651858.CD001862.pub3.

[Kapoor-1] Kapoor VS, Whyte R, Vedula SS (2016). "Interventions for preventing ophthalmia neonatorum". Cochrane Database Syst Rev. 9: CD001862. doi:10.1002/14651858.CD001862.pub3.

[1]